fig2
From: Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease
Figure 2. HPCs in NASH with moderate fibrosis (F2 stage) (needle biopsy sample). Keratin 7 immunostaining decorates the interlobular bile ducts, ductular reaction/HPCs (arrows). HPCs: hepatic progenitor cells; NASH: non-alcoholic steatohepatitis
